GE HealthCare prices upsized secondary offering of 15M shares at $86; no proceeds to company

GE HealthCare Technologies Inc.

Secondary offering upsized from 10M to 15M shares at $86.00/share; underwriters have option for 2.25M additional shares.
Selling stockholder Morgan Stanley & Co. LLC will sell shares after debt-for-equity exchange by GE Aerospace (General Electric).
GE HealthCare will not receive any proceeds from the offering or the exchange.
Offering expected to close September 16, 2024; Morgan Stanley and Citigroup are lead book-running managers.
Net proceeds from the sale will go to GE Aerospace (via debt exchange) and Morgan Stanley as selling stockholder.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.